Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Prometic Snags Rare Pediatric Disease Designation from the FDA for its Inter-Alpha-Inhibitor-Protein

biospaceMarch 06, 2018

Tag: FDA , Alpha-Inhibitor-Proteins

PharmaSources Customer Service